Understanding how a protein called 14-3-3ζ affects the health of cells in the pancreas
14-3-3-zeta regulation of islet health
This research explores how a specific protein helps control the cells in the pancreas that make insulin and other hormones, aiming to improve treatments for type 2 diabetes.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project ID | NIH-11129854 on NIH RePORTER |
What this research studies
Our bodies rely on special cells in the pancreas, called islet cells, to manage blood sugar. In type 2 diabetes, these cells don't work as well as they should, affecting both insulin-producing beta cells and glucagon-producing alpha cells. We've found a protein, 14-3-3ζ, that seems to play a key role in how these cells function and communicate with each other. By understanding how this protein works, especially in human islet cells, we hope to uncover new ways to help these cells work better. This could lead to more effective strategies for managing type 2 diabetes.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but focuses on understanding the cellular mechanisms relevant to individuals with type 2 diabetes.
Not a fit: Patients without type 2 diabetes or related pancreatic islet dysfunction may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new drug targets or therapies that improve the function of pancreatic cells, offering better ways to treat or prevent type 2 diabetes.
How similar studies have performed: This research builds upon recent findings from the lab demonstrating the role of 14-3-3ζ in mouse and human islets, suggesting a promising new direction.
Where this research is happening
Davis, United States
- University of California at Davis — Davis, United States (Active)
Researchers
- Principal investigator: Cummings, Bethany Paige — University of California at Davis
- Study coordinator: Cummings, Bethany Paige
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.